Literature DB >> 27636513

Synthesis of stable nanosilver particles (AgNPs) by the proteins of seagrass Syringodium isoetifolium and its biomedicinal properties.

N K Ahila1, V Sri Ramkumar2, S Prakash3, B Manikandan4, J Ravindran4, P K Dhanalakshmi5, E Kannapiran6.   

Abstract

A simple eco-friendly approach for the hasty synthesis of stable, potent and benign silver nanoparticles (AgNPs) using seagrass, Syringodium isoetifolium was proposed and described here. The UV-Vis, DLS, XRD, AFM, FESEM, EDX and HRTEM analysis highly characterized and confirmed the presence of polydispersed (2-50nm) spherical and stable AgNPs. FT-IR and phytochemical analysis suggested that the proteins act as reducing and also as capping agent. A hypothetical approach using bioinformatics tools revealed that the Phytochrome B protein of S. isoetifolium might be responsible for the biosynthesis of NPs. Furthermore, biosynthesized AgNPs showed magnificent antibacterial activity against thirteen clinical bacterial pathogens with maximum zone of inhibition of 14.3±0.12mm due to their smaller size and longer stability even at minimal nanomolar (nM) concentration. In addition, the MIC and MBC values also suggested the same. Moreover, the percentage of haemolysis (8.49±3.10 to 73.34±1.79%) and haemolytic index revealed the satisfactory biocompatibility of AgNPs that showed less/no haemolysis up to 3nM concentration. Further, the toxicity effect of biosynthesized AgNPs against the brine shrimp, Artemia salina exhibited significantly increasing mortality (13±4.7 to 100%) with LC50 value at 4nM concentration. Thus, the optical property, crystal structure, size, shape, stability, bactericidal activity, cytotoxicity, and biocompatibility apparently proved that the biologically synthesized AgNPs have typical properties of nanomaterials.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AgNPs; Antibacterial activity; Cytotoxicity; Haemolysis; Phytochrome-B; Seagrasses; Syringodium isoetifolium

Mesh:

Substances:

Year:  2016        PMID: 27636513     DOI: 10.1016/j.biopha.2016.09.004

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

Review 1.  Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.

Authors:  Vivek K Bajpai; Shruti Shukla; Sung-Min Kang; Seung Kyu Hwang; Xinjie Song; Yun Suk Huh; Young-Kyu Han
Journal:  Mar Drugs       Date:  2018-05-23       Impact factor: 5.118

2.  Biosynthesis of silver nanoparticles with antimicrobial and anticancer properties using two novel yeasts.

Authors:  Xin Liu; Jia-Le Chen; Wen-Yu Yang; Yu-Cheng Qian; Jing-Yu Pan; Chen-Nianci Zhu; Li Liu; Wen-Bin Ou; Hong-Xin Zhao; Dian-Peng Zhang
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.